Arcutis Biotherapeutics, Inc.ARQTNASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending higher, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-109.63M
↑ 14% above average
Average (7y)
$-126.83M
Historical baseline
Range
High:$480000.00
Low:$-294.55M
CAGR
+99.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-109.63M | +51.8% |
| 2023 | $-227.43M | +22.8% |
| 2022 | $-294.55M | -43.3% |
| 2021 | $-205.59M | -52.0% |
| 2020 | $-135.22M | -223.5% |
| 2019 | $-41.80M | -8808.5% |
| 2018 | $480000.00 | +155.0% |
| 2017 | $-872000.00 | - |